Related Experiment Video
Updated: Aug 19, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
Spontaneous speech feature analysis for alzheimer's disease screening using a random forest classifier.
1Department of Electrical, Computer, and Biomedical Engineering, Toronto Metropolitan University, Toronto, Ontario, Canada.
Frontiers in Digital Health
|December 5, 2022
Summary
Machine learning models can detect Alzheimer's disease (AD) and its progression using speech analysis. This non-invasive method offers early diagnosis and monitoring of cognitive decline.
Area of Science:
- Neurology
- Computational Linguistics
- Biomedical Engineering
Background:
- Alzheimer's disease (AD) diagnosis and monitoring are crucial for patient care.
- Current methods can be invasive, costly, or time-consuming.
- Speech analysis offers a potential non-invasive, cost-effective alternative.
Purpose of the Study:
- To predict early Alzheimer's disease (AD) diagnosis using speech data.
- To evaluate the stages of AD progression through acoustic feature analysis.
- To explore the utility of machine learning (ML) for AD detection via speech.
Main Methods:
- Collected spontaneous speech signals from individuals with AD and cognitively normal (CN) subjects.
- Performed exploratory analysis of acoustic features, non-stationarity, and non-linearity.
- Applied data augmentation techniques to enhance speech signal datasets.
- Utilized a Random Forest classifier for AD prediction and staging.
Main Results:
- Achieved an 82.2% accuracy rate for early AD prediction.
- Attained a 71.5% accuracy rate for classifying AD stages.
- Demonstrated the potential of acoustic and linguistic features in speech for AD detection.
Conclusions:
- Speech analysis combined with ML provides a promising avenue for non-invasive AD detection and monitoring.
- Further research into non-stationarity and non-linearity in audio features can refine AD classification models.
- This approach can significantly aid early diagnosis and repetitive monitoring of Alzheimer's disease progression.
Keywords:
Alzheimer's diseaseacoustic featuresclassificationdata augmentationmachine learningnon-linearitynon-stationarityspontaneous speechMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
612
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
612
Alzheimer's Disease: Treatment
240
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
240

